Official Title: A Randomized Double-Blind Placebo-Controlled Study of Dronabinol in the Treatment of Marijuana Addiction
Status: COMPLETED
Status Verified Date: 2019-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MARINOL
Brief Summary: The purpose of this study is to determine if dronabinol decreases the symptoms of marijuana addiction and withdrawal
Detailed Description: Marijuana addiction is associated with significant withdrawal symptoms including anxiety irritability bodily discomfort and insomnia The purpose of this study is to determine the effectiveness of dronabinol in reducing withdrawal symptoms
During this twelve-week double-blind placebo-controlled study study visits will occur twice each week During study visits participants will receive either placebo or medication Throughout the study all participants will receive individualized psychotherapy sessions At each study visit vital signs self-report ratings and urine samples will be collected Participants will have a follow-up evaluation at month 6